$BMY with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BMY after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 33.33%.
1BMY trade ideas
BMY triple top long term chart overbought!Bought 100 BMY May 6th $75 puts. Will add for each $1.00 increase.
BMY - ACCENDING TRIANGLETextbook pattern. Pharma products going through the roof due to covid and other reasons why this would be in high demand, also not too mention big investors adding to their portfolio.
Plenty of info online, please research before investing obv.
trade safe all.
$BMY Bristol-Myers Squibb Company - Forming a baseThis might be forming a long-term base here. I'm long with a stop-loss at $62 (has to be a weekly close below $62). Part of my longest-term trading system.
BMY Long Play Bristol-Myers Squibb Company (BMY) is a biopharmaceutical company that engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis.
Investments continue to flow into the healthcare industry and BMY is ripe to benefit. Adding it long
$BMY with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BMY after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 20%.
Bristol Myers Squibb Cup and Handle with 400% gain?Looks like a possible Cup and Handle with massive upside is forming in Bristol Myers Squibb.
$340 Target
BMY going South with a breeze. BMYImmediate targets 61, 59, 56, 53. Invalidation at 79.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe
BMY Long Term LongHealthy pipeline.
Sitting at 3.32% yield and 8.62 P/E (norm is 18.65 and 5Y norm is 11.17) with earnings growth rate approx. 6.18% since 2000 but has increased to 15-16% if you look at the 10Y and 5Y norms.
Estimates are for about 4-6% the next 2 years.
A+ Credit Rating
48LT Debt to Cap
PT $96 by 2023 using a 7% earnings growth rate and 12 P/E
HUGE saucer pattern -- technically.
Bristol Myers going South. BMYImmediate targets 61,59, 56, 53. Invalidation at 79.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe
BMY to break out in the next several yearsBMY is presently in a wedge. Though a breakdown is certainly possible over the next decade, what are reasonable breakout levels to watch? This chart with Fib levels induced by the move from all-time lows to all-time highs gives some clues.
Approximately $75 is first up, then approximately $120.
BMY: Breakout of the long-term resistance level.An upward breakout of the long-term resistance level could lead to an increase in the area of 81. In the long-term, the growth could continue to the area of 93.
$BMY bouncing off long-term support (4/5)Conviction: 4/5
might be better to buy when the stock goes over 1998 resistance
General Thesis
bouncing off of multi-cycle support (since 1974)
Weekly RSI showing sliiight bullish divergence
Growth
Margins quite low compared to own history
low growth
Value
very cheap
Fundamentals
low debt/asset ratio and plenty of cash to deal with short term debts
Potential Risks
expensive market...
long-term resistance around 76 since 1998
BMY Pays a dividend. This has a lot of different bullish patterns and if it falls through the floor, I'll laugh histaricly. Cup n' handle, bull-flaf, IHS. I'll leave a channel but feel free to find waldo! Cheers.
Bristol Myers Squibb Announces Dividend Increase and Additional BMY: Bristol-Myers Squibb Company
2021-12-13 06:59:00
Bristol Myers Squibb Announces Dividend Increase and Additional $15 Billion Share Repurchase Authorization
Buy $BMY - NRPicks 08 OctBristol-Myers Squibb Co. discovers, develops, licenses, manufactures and markets biopharmaceuticals worldwide. It offers products in hematology, oncology, cardiovascular and immunology therapeutic classes. It has agreements with Pfizer and Otsuka Pharmaceutical Co., Ltd.
Revenue TTM 44.3B
EBITDA TTM 18.8B
EBITDA margin TTM 42.4% P/S 2.94
P/S 2.94
Dividend yield 3.2%
QuickTradeBullish cross of my EMAs.
Stop at 58.08
Notes : The daily is so close and may act as resistance.
I AM BULLISH ON BMYrisk reward tool gives you idea about ENTRY ,STOP LOSS AND TARGET
yes its good time to invest
when I get the idea that this script is not bullish anymore I will let you know guy
BMYCould be trying to bounce here. Holding up after earnings, bullish rsi divergence, & near support at the 0.382 retracement. ABBV is having a solid reaction after its earnings today. Thinking BMY might try to follow.
